Abstract
The cytotoxic T-cell (Tc) response to varicella-zoster virus (VZV) is incompletely characterized. We investigated whether VZV-specific Tc restricted by class I products of the major histocompatibility complex can be generated from the peripheral blood of VZV-immune donors. Cell lines were established from peripheral blood lymphocytes (PBL) of seropositive donors by secondary in vitro restimulation. If cell-free VZV was used as the stimulating antigen, the resulting lines were predominantly CD4+ and did not show class I-restricted cytotoxicity; when autologous infected fibroblasts were used for in vitro stimulation, the resultant lines were usually cytotoxic, although in only 4 of 11 subjects tested was this cytotoxicity HLA restricted and virus specific. PBL were also tested for Tc activity without prior restimulation; VZV-specific Tc activity was only demonstrable in the PBL of a subject convalescent following zoster but not from subjects with recent varicella infection or from normal subjects. VZV-specific Tc precursor frequencies were then determined in six selected subjects by limiting-dilution analysis. A measurable frequency was detectable in four of the six seropositive subjects, ranging from 11/10(6) T cells in an asymptomatic carrier, to 63/10(6) T cells in a subject with recent zoster. We conclude that virus-specific major histocompatibility complex class I-restricted Tc precursors may be present in the peripheral blood of normal individuals seropositive for VZV but at a frequency lower than that for other herpesviruses with nonneuronal sites of latency.
MeSH Terms
Cell Line
Cell Transformation, Viral
Cytotoxicity, Immunologic
Fibroblasts/immunology
HLA Antigens/genetics
Herpes Zoster/immunology
Herpesvirus 3, Human/genetics,immunology
Humans
Skin/immunology
T-Lymphocytes, Cytotoxic/immunology,microbiology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Hickling J K
MRC Clinical Immunology Research Group, Royal Postgraduate Medical School, London, United Kingdom.
Borysiewicz L K
Sissons J G
References (20)
20 references, click to expand
-
Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia.
J Pediatr. 1979 Feb;94(2):223-30
PMID: 762611
-
Viral infections in man associated with acquired immunological deficiency states.
Fed Proc. 1971 Nov-Dec;30(6):1858-64
PMID: 4333313
-
Development and characteristics of the cellular immune response to infection with varicella-zoster virus.
J Infect Dis. 1980 Jan;141(1):7-13
PMID: 6245148
-
Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.
Infect Immun. 1980 Aug;29(2):369-75
PMID: 6163709
-
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.
J Immunol. 1981 May;126(5):2036-41
PMID: 6260861
-
Long-term T-cell-mediated immunity to Epstein-Barr virus.
Cancer Res. 1981 Nov;41(11 Pt 1):4216-21
PMID: 6272965
-
T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations.
J Immunol Methods. 1982;50(1):39-49
PMID: 6979583
-
HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.
Infect Immun. 1983 Apr;40(1):190-7
PMID: 6187690
-
Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.
J Exp Med. 1983 Aug 1;158(2):571-85
PMID: 6224883
-
Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
Eur J Immunol. 1983 Oct;13(10):804-9
PMID: 6196203
-
Varicella-zoster virus DNA in human sensory ganglia.
Nature. 1983 Dec 1-7;306(5942):478-80
PMID: 6316159
-
In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients.
Int J Cancer. 1985 Jan 15;35(1):43-9
PMID: 2981781
-
Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients.
Clin Exp Immunol. 1985 May;60(2):387-95
PMID: 2988834
-
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.
J Exp Med. 1986 Apr 1;163(4):903-21
PMID: 3485173
-
Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.
J Virol. 1986 Apr;58(1):179-84
PMID: 3005647
-
Cellular interactions in the lysis of varicella-zoster virus infected human fibroblasts.
Clin Exp Immunol. 1986 Jan;63(1):141-6
PMID: 3485481
-
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
J Infect Dis. 1986 Sep;154(3):422-9
PMID: 3016110
-
Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
J Virol. 1986 Aug;59(2):506-9
PMID: 3016312
-
Immunology. The ins and outs of antigen processing and presentation.
Nature. 1986 Aug 21-27;322(6081):687-9
PMID: 3489186
-
HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells.
Nature. 1980 Feb 28;283(5750):865-7
PMID: 6244495